Cargando…

An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice

Instruction: Rift valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that causes severe disease in animals and humans. Nevertheless, there are no vaccines applied to prevent RVFV infection for human at present. Therefore, it is necessary to develop a safe and effective RVFV vaccine. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Meng, Bian, Ting, Fu, Guangcheng, Chen, Yi, Fang, Ting, Zhao, Chuanyi, Liu, Shuling, Yu, Changming, Li, Jianmin, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011166/ https://www.ncbi.nlm.nih.gov/pubmed/36925463 http://dx.doi.org/10.3389/fmicb.2023.1114226

Ejemplares similares

Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge
por: Bian, Ting, et al.
Publicado: (2022)

Active Surveillance in the investigation and analysis of RVF in Western and Central Uganda
por: Nanfuka, Mary L., et al.
Publicado: (2019)

RVFV Infection in Goats by Different Routes of Inoculation
por: Kroeker, Andrea L., et al.
Publicado: (2018)

Increased Susceptibility of Cattle to Intranasal RVFV Infection
por: Kroeker, Andrea L., et al.
Publicado: (2020)

Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
por: Monath, Thomas P., et al.
Publicado: (2020)

Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system
por: Ibrahim, Essam H., et al.
Publicado: (2019)

Metabolomic profile of medicinal plants with anti-RVFV activity
por: More, Garland Kgosi, et al.
Publicado: (2022)

Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection
por: Chen, Huixin, et al.
Publicado: (2020)

NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo
por: Li, Shufen, et al.
Publicado: (2019)

Influence of RVFV Infection on Olfactory Perception and Behavior in Drosophila melanogaster
por: Bergmann, Stella, et al.
Publicado: (2023)

A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
por: Bian, Ting, et al.
Publicado: (2023)

Author Correction: A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
por: Bian, Ting, et al.
Publicado: (2023)

Trapping of Rift Valley Fever (RVF) vectors using Light Emitting Diode (LED) CDC traps in two arboviral disease hot spots in Kenya
por: Tchouassi, David P, et al.
Publicado: (2012)

Development of a RVFV ELISA that can distinguish infected from vaccinated animals
por: McElroy, Anita K, et al.
Publicado: (2009)

The Atypical Kinase RIOK3 Limits RVFV Propagation and Is Regulated by Alternative Splicing
por: Havranek, Katherine E., et al.
Publicado: (2021)

Computing the Structural Dynamics of RVFV L Protein Domain in Aqueous Glycerol Solutions
por: Gogovi, Gideon K., et al.
Publicado: (2021)

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
por: Wu, Shipo, et al.
Publicado: (2020)

Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge
por: Sun, Jialei, et al.
Publicado: (2016)

Characterization of Lethal Zika Virus Infection in AG129 Mice
por: Aliota, Matthew T., et al.
Publicado: (2016)

Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model
por: Campos, Rafael Kroon, et al.
Publicado: (2020)

An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep
por: Said, Abdelrahman, et al.
Publicado: (2017)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
por: Stedman, Anna, et al.
Publicado: (2019)

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Correction: Characterization of Lethal Zika Virus Infection in AG129 Mice
por: Aliota, Matthew T., et al.
Publicado: (2016)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

Enhanced surveillance for Rift Valley Fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015-2016
por: Oyas, Harry, et al.
Publicado: (2018)

Rift Valley fever (RVF): a re-emerging zoonotic disease, pathogenesis, epidemiology, current status, and future perspective – correspondence
por: Akash, Shopnil, et al.
Publicado: (2023)

NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection
por: Michaely, Lukas Mathias, et al.
Publicado: (2022)

Comparison of RT-qPCR and RT-ddPCR with Rift valley fever virus (RVFV) RNA
por: Park, Changwoo, et al.
Publicado: (2023)

A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection
por: López-Gil, Elena, et al.
Publicado: (2013)

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
por: Feng, Liqiang, et al.
Publicado: (2020)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Alteration in Superoxide Dismutase 1 Causes Oxidative Stress and p38 MAPK Activation Following RVFV Infection
por: Narayanan, Aarthi, et al.
Publicado: (2011)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Establishment of a New Zealand White Rabbit Model for Lethal Toxin (LT) Challenge and Efficacy of Monoclonal Antibody 5E11 in the LT-Challenged Rabbit Model
por: Zhang, Duanyang, et al.
Publicado: (2018)

A Novel Quadruple Gene-Deleted BoHV-1-Vectored RVFV Subunit Vaccine Induces Humoral and Cell-Mediated Immune Response against Rift Valley Fever in Calves
por: Pavulraj, Selvaraj, et al.
Publicado: (2023)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge
por: Gowen, Brian B., et al.
Publicado: (2014)

A Novel Fiber-1-Edited and Highly Attenuated Recombinant Serotype 4 Fowl Adenovirus Confers Efficient Protection Against Lethal Challenge
por: Mu, Yaru, et al.
Publicado: (2021)

A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice
por: Milligan, Gregg N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0eskf9mghl8t8ovhipopo66phu